HEPATITIS D
Clinical trials for HEPATITIS D explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS D trials appear
Sign up with your email to follow new studies for HEPATITIS D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to tame dangerous liver virus
Disease control OngoingThis study is testing whether an experimental injection called Hepalatide (L47) can help control Hepatitis D, a serious liver infection. It will enroll 90 adults with stable liver function to receive either a low dose, a high dose, or delayed treatment for 48 weeks. The main goal…
Matched conditions: HEPATITIS D
Phase: PHASE2 • Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hepatitis d drug tested for preventing deadly liver complications
Disease control OngoingThis study investigates whether a new antiviral drug called Bulevirtide can reduce dangerous high pressure in the liver (portal hypertension) in people with both hepatitis B and hepatitis D infections who also have liver scarring (cirrhosis). Researchers are measuring pressure ch…
Matched conditions: HEPATITIS D
Sponsor: Hannover Medical School • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC